Keeping Current CME podcast

JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact

0:00
38:19
Reculer de 15 secondes
Avancer de 15 secondes

See where Janus kinase (JAK) inhibitors fit into rheumatoid arthritis (RA) treatment to tackle obstacles and improve patient outcomes.

Credit available for this activity expires: 12/10/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu

D'autres épisodes de "Keeping Current CME"